跳至主要内容
临床试验/NCT00496522
NCT00496522进行中(未招募)2 期

Phase II Evaluation of Proton Beam Therapy for Skull Base Chondrosarcoma

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2006年4月28日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
15
试验地点
1
主要终点
Time to Local Recurrence

研究概览

简要总结

The goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chondrosarcoma. The safety of this treatment will also be studied.

详细描述

Patients who have skull base chondrosarcoma require complicated treatment because of its challenging location and nearness to critical structures within the brain.

Pathology will be confirmed prior to discussion of the study.

If you are found to be eligible to take part in this study, you will receive proton beam therapy, no sooner than 2 weeks after the last surgery to remove tumor. You will receive proton beam therapy once a day for about 35 treatments (7 weeks). Treatment will be given for 5 days in a row each week (except for Saturdays, Sundays, and holidays) at the Proton Center in Houston. The whole process should take up to 1 hour each day.

If your doctor feels it is necessary, the proton beam therapy may be combined with standard photon therapy.

After the proton beam, and possibly photon beam, therapy, you will be asked to come in for study follow-up visits every year, until the study is completed. At these visits, you will have magnetic resonance imaging (MRI) scans, blood draws (less than 1 teaspoon) to monitor your pituitary function, and neuropsychological testing. For the neuropsychological testing, you will be interviewed and tested by a neuropsychologist to evaluate your memory, fluency (the ability to talk and form words) complex thinking ability, planning ability, and coordination. These tests could last from 1-2 hours. You will also have eye exams performed by an ophthalmologist from MD Anderson and hearing exams. It is anticipated that it will take about 5 years to complete this study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Pathologically confirmed Grade 1-3 chondrosarcoma of the skull base
  • Contrast enhanced postop MRI or CT if there is clinical contraindication for MRI of the skull base obtained with 90 days of study registration at M. D. Anderson
  • The patient has been assessed by MDACC skull base surgeons to have undergone maximal surgical debulking of disease
  • Karnofsky Performance status greater than or equal to 60
  • Signed informed consent

排除标准

  • Previous irradiation of the skull base
  • Documented evidence of disseminated metastatic disease

研究组 & 干预措施

Proton Beam Therapy

Other

Proton Beam Therapy - A total dose of up to 70 CGE given at 2.0 CGE per daily fraction for 35 fractions.

干预措施: Proton Beam Therapy (Procedure)

结局指标

主要结局

Time to Local Recurrence

时间窗: Baseline to local recurrence (evaluation every six months during estimated 5 year study)

Local recurrence defined as progression on magnetic resonance imaging (MRI) or CT if MRI is contraindicated.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验